Annual Total Long Term Liabilities
$4.08 M
-$1.23 M-23.16%
31 December 2023
Summary:
Jasper Therapeutics annual total long term liabilities is currently $4.08 million, with the most recent change of -$1.23 million (-23.16%) on 31 December 2023. During the last 3 years, it has fallen by -$50.40 million (-92.51%). JSPR annual total long term liabilities is now -92.51% below its all-time high of $54.48 million, reached on 31 December 2020.JSPR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$3.27 M
-$277.00 K-7.80%
30 September 2024
Summary:
Jasper Therapeutics quarterly total long term liabilities is currently $3.27 million, with the most recent change of -$277.00 thousand (-7.80%) on 30 September 2024. Over the past year, it has dropped by -$1.09 million (-25.01%). JSPR quarterly long term liabilities is now -93.99% below its all-time high of $54.48 million, reached on 31 December 2020.JSPR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -25.0% |
| 3 y3 years | -92.5% | -83.2% |
| 5 y5 years | - | - |
JSPR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -92.5% | at low | -83.2% | at low |
| 5 y | 5 years | -92.5% | at low | -94.0% | at low |
| alltime | all time | -92.5% | at low | -94.0% | at low |
Jasper Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.27 M(-7.8%) |
| June 2024 | - | $3.55 M(-7.0%) |
| Mar 2024 | - | $3.82 M(-6.4%) |
| Dec 2023 | $4.08 M(-23.2%) | $4.08 M(-6.6%) |
| Sept 2023 | - | $4.37 M(-12.6%) |
| June 2023 | - | $4.99 M(-11.9%) |
| Mar 2023 | - | $5.67 M(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.31 M(-67.1%) | $5.31 M(+28.7%) |
| Sept 2022 | - | $4.12 M(-16.9%) |
| June 2022 | - | $4.96 M(-23.3%) |
| Mar 2022 | - | $6.47 M(-59.8%) |
| Dec 2021 | $16.12 M(-70.4%) | $16.12 M(-17.1%) |
| Sept 2021 | - | $19.45 M(-64.3%) |
| Dec 2020 | $54.48 M | $54.48 M |
FAQ
- What is Jasper Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics annual total long term liabilities year-on-year change?
- What is Jasper Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly long term liabilities year-on-year change?
What is Jasper Therapeutics annual total long term liabilities?
The current annual total long term liabilities of JSPR is $4.08 M
What is the all time high annual total long term liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total long term liabilities is $54.48 M
What is Jasper Therapeutics annual total long term liabilities year-on-year change?
Over the past year, JSPR annual total long term liabilities has changed by -$1.23 M (-23.16%)
What is Jasper Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of JSPR is $3.27 M
What is the all time high quarterly long term liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total long term liabilities is $54.48 M
What is Jasper Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, JSPR quarterly total long term liabilities has changed by -$1.09 M (-25.01%)